Cmlase

Cmlase has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest story, Oct 28, 2026: “Enzyme reduces a form of protein damage in human tissue”.

Intervention

1 paper studies it1 findingUpdated

See all 1

“We demonstrate that CMLase effectively reverses CML modifications in model proteins in vitro and in human tissue samples from elderly donors”
Reversal of protein chemical aging by enzymatic deglycationNature communications2026doi:10.1038/s41467-026-75141-2
  • 1 lab in 1 country
  • Funder: National Institutes of Health
  • 1 of 1 finding with company ties
  • Humans1

What did studies of Cmlase find?

1

Studies of Cmlase measured 1 outcome; the most studied are Nε-(carboxymethyl)lysine (1 study).

Nε-(carboxymethyl)lysine

downin humans1

1 study
  1. Cmlase is linked with lower Nε-(carboxymethyl)lysine in humans.

    “We demonstrate that CMLase effectively reverses CML modifications in model proteins in vitro and in human tissue samples from elderly donors”

    Humanstissue

    Enzyme reduces a form of protein damage in human tissue

    Nature communications

More on Nε-(carboxymethyl)lysine

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 paper in 12 months
Nature Communications

Enzyme reduces a form of protein damage in human tissue

Overnight exposure reduced an age-linked protein modification by 45% in lens proteins from a 64-year-old donor, compared with untreated samples.Overnight exposure reduced an age-linked protein modification by 45% in lens proteins from a 64-year-old donor, compared with untreated samples.

Human cell studyInterventions